Matt Jamison
Managing Director/President
Matt Jamison is President and Managing Director of PMCF. He has more than 30 years of professional experience advising clients on strategic and financial alternatives, sale and acquisition transactions, divestitures, and recapitalizations. His past clients include privately-owned businesses, private equity groups, and public corporations across various industries, including business services & technology, consumer, food & retail, plastics & packaging, industrials, and healthcare. Matt has significant experience originating and executing deals both domestically and internationally, and is a board member of Corporate Finance International, the global investment banking affiliate of PMCF. As President of PMCF, Matt provides strategic, operational, and financial direction to the firm. In addition, he is responsible for managing client relationships, leading transaction teams, and actively marketing the services of PMCF to potential clients.
Prior to joining PMCF, Matt worked as an international consultant and CPA for Plante Moran. He transitioned to the role of Vice President at PMCF soon after it was founded. While at PMCF, Matt helped the firm evolve from a generalist practice to an industry-focused middle market investment bank. He launched the Plastics & Packaging practice and transitioned it to new leadership shortly after his promotion to Managing Director. Matt then focused his efforts on growing additional industries for the firm, and he currently co-leads the Business Services & Technology industry groups. Matt has written numerous articles and is a frequent speaker to business media and industry organizations on various investment banking topics.
Matt earned a BA in accounting from Hillsdale College and earned his MBA from the Stephen M. Ross School of Business at the University of Michigan. He is a licensed securities representative holding his Series 7, 24, and 63 registrations.
Human Capital Management M&A Pulse – Q3 2024
Following unprecedented post-pandemic performance in 2022, the Human Capital Management Industry has undergone a lengthy period of “right sizing” as demand for temporary labor has declined and key client industries, such as manufacturing and warehousing, have stagnated in terms of total employment.
Medical Technology M&A Pulse – Q2 2024
Ongoing volatility in the Medical Technology M&A sector is driving heightened diligence and investor scrutiny to ensure acquisition targets are high-quality assets capable of withstanding current market turbulence.
Human Capital Management M&A Pulse – Q2 2024
The U.S. Staffing Industry has demonstrated resiliency through the first half of 2024, while advancements in talent acquisition technologies and a strong demand base continue to combat downturns in key client industries, such as manufacturing and warehousing.
Medical Technology M&A Pulse – Q1 2024
Persistent inflation in Q1 2024 delayed expected rate cuts as the Federal Reserve back tracked expectations from four to three cuts this year.
Human Capital Management M&A Pulse – Q1 2024
The U.S. Staffing Industry is anticipated to remain mostly flat through 2024 as a result of ongoing normalization following multiple years of record-breaking growth.
